Modern opportunities for optimising the treatment of patients with coronary heart disease and arterial hypertension: role of zofenopril

Modern opportunities for optimising the treatment of patients with coronary heart disease and arterial hypertension: role of zofenopril

The wide prevalence (82%) of coronary heart disease (CHD) in combination with arterial hypertension (AH), as well as its initiating role in the development of fatal complications, such as myocardial infarction (MI) or heart failure, emphasise the need for the choice of optimal ACE inhibitors with or...

Full description

Bibliographic Details
Main Authors:	A. G. Evdokimova, V. V. Evdokimov, N. V. Leonenko, A. V. Smetanin
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2012-08-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	zofenopril coronary heart disease arterial hypertension clinical case literature review
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/1880

Similar Items

Features of zofenopril and enalapril in patients with stable ischemic heart disease in combination with arterial hypertension
by: A. G Evdokimova, et al.
Published: (2016-06-01)

Zofenopril in the treatment of patients with arterial hypertension and stable coronary heart disease: effects on oxidative stress and flowdependent vasodilatation
by: F. T. Ageev, et al.
Published: (2011-06-01)

ACE inhibitors in arterial hypertension management: zofenopril – class-specific effects and extra benefits
by: V. S. Zadionchenko, et al.
Published: (2007-04-01)

OPTIMISATION OF ARTERIAL HYPERTENSION PHARMACOTHERAPY IN PATIENTS WITH METABOLIC SYNDROME: POTENTIAL OF ZOFENOPRIL
by: T. E. Morozova, et al.
Published: (2011-08-01)

СHOICE OF ZOFENOPRIL AND HYDROCHLOROTHIAZIDE COMBINATION IN THE TREATMENT OF ARTERIAL HYPERTENSION
by: N. A. Dzhaiani
Published: (2016-01-01)

Whether all ACE inhibitors enzyme are identical? Focus on zofenopril.
by: Lyudmila Gennadievna Ratova, et al.
Published: (2009-09-01)

Comparative evaluation of zofenopril. Are the characteristics of angiotensin I converting enzyme inhibitors important for the practice?
by: A A Kirichenko
Published: (2014-09-01)

Antiremodelling Efficacy and Clinical Safety of Zofenopril in Patients with Grade 1and 2 Hypertension
by: Guzal J. Abdullaeva, et al.
Published: (2015-12-01)

Combination antihypertensive therapy in patients with arterial hypertension and coronary heart disease
by: T. E. Morozova, et al.
Published: (2013-08-01)

POTENTIAL OF THE MODERN ACE INHIBITOR ZOFENOPRIL IN CLINICAL PRACTICE: CARDIOPROTECTIVE, ANTI-ISCHEMIC, AND ANTIATHEROGENIC EFFECTS
by: M. G. Bubnova
Published: (2013-02-01)

The effectiveness of zofenopril in patients with cardiovascular disease
by: V G Kukes, et al.
Published: (2014-06-01)

Correction of Endothelial Dysfunction in Patients with Essential Hypertension when Using a Combination of Olmesartan/Lercanidipine and Zofenopril/Lercanidipine
by: O. V. Zimnitskaya, et al.
Published: (2016-11-01)

Safety and efficacy of the sulfydryl ACE-inhibitor zofenopril in the management of cardiovascular disease
by: C. Napoli
Published: (2011-12-01)

ACE INHIBITOR ZOFENOPRIL IN COMPLEX THERAPY OF CHRONIC HEART FAILURE AND DILATED CARDIOMYOPATHY
by: Z. T. Astakhova, et al.
Published: (2010-04-01)

Protective Effects of Zofenopril on Testicular Torsion and Detorsion Injury in Rats
by: Bülent Altunoluk, et al.
Published: (2011-11-01)

ACE inhibitor zofenopril in treatment of myocardial infarction patients: review of SMILE Project trials
by: Yu. M. Lopatin
Published: (2006-04-01)

Evaluation of the influence of the therapy with fosinopril and zofenopril on the regulatory-adaptive status of patients with diastolic chronic heart failure
by: Svetlana N. Nedvetskaya, et al.
Published: (2019-12-01)

Clinical role of cardioprotective and vasculoprotective effects of АСЕ inhibitors in myocardial infarction: zofenopril
by: G. K. Кiyakbaev
Published: (2008-12-01)

POTENTIAL OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS IN THE TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION AND CORONARY HEART DISEASE
by: A. G. Evdokimova, et al.
Published: (2013-02-01)

BAZI İÇECEKLERDE TİTRASYON ASİTLİĞİNİN TAYİNİ İÇİN ZOFENOPRİL KALSİYUMA DAYANAN pH ELEKTROT YAPIMI
by: H. Elif Kormalı Ertürün
Published: (2017-06-01)

Pleiotropic ACE inhibitor effects: any benefits for sulfhydryl agents?
by: D. V. Preobrazhensky, et al.
Published: (2008-02-01)

PHARMACOECONOMIC STUDY OF OLMESARTAN/LERCANIDIPINE AND OFENOPRIL/LERCANIDIPINE COMBINATIONS IN THE TREATMENT OF PATIENTS WITH ESSENTIAL HYPERTENSION
by: D. S. Kaskaeva, et al.
Published: (2017-03-01)

Osobennosti kardioprotektivnogo deystviyazofenoprila vo vtorichnoy profilaktikeserdechno-sosudistykh zabolevaniy
by: Nikolay Aleksandrovich Vaulin
Published: (2011-03-01)

Endothelial dysfunction and prognosis after coronary interventions in patients with coronary heart disease and arterial hypertension
by: M. V. Kazak, et al.
Published: (2011-10-01)

Combined antihypertensive therapy in patients with arterial hypertension and coronary heart disease
by: O. A. Ageenkova, et al.
Published: (2011-06-01)

OXIDATIVE STRESS AND POSSIBILITY TO CORRECT IT WITH ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN PATIENTS WITH MYOCARDIAL INFARCTION ASSOCIATED WITH DIABETES MELLITUS TYPE 2
by: K. S. Lexina, et al.
Published: (2015-12-01)

Possibilities for correcting endothelial dysfunction in patients with arterial hypertension and coronary heart disease
by: E. V. Filippov
Published: (2019-04-01)

Bisoprolol effectiveness in arterial hypertension and coronary heart disease
by: O. D. Ostroumova, et al.
Published: (1970-01-01)

Hypertensive crises in patients with essential arterial hypertension and coronary heart disease: new perspectives in treatment and prevention
by: A. P. Golikov, et al.
Published: (2005-06-01)

User guide of Russian registry of patients with arterial hypertension, coronary artery disease and chronic heart failure
by: Oshchepkova E.V., et al.
Published: (2014-06-01)

Dysfunction of vascular endothelium at arterial hypertension and coronary disease (literature review)
by: L. B. Koryakina, et al.
Published: (2013-04-01)

Arterial hypertension and stress-induced arrhythmias in coronary heart disease patients
by: L. A. Leshchinsky, et al.
Published: (2005-06-01)

Arterial hypertension and myocardial electric heterogeneity in patients with coronary heart disease
by: L. A. Leshchinsky, et al.
Published: (2005-06-01)

ELECTRO-MECHANICAL HEART REMODELLING AND ATRIAL FIBRILLATION DEVELOPMENT IN PATIENTS WITH CORONARY HEART DISEASE AND ARTERIAL HYPERTENSION
by: D. V. Dedov, et al.
Published: (2011-08-01)

Coronary heart disease and arterial hypertension prevalence dynamics in Tumen female population: five-year monitoring
by: E. V. Akimova, et al.
Published: (2007-02-01)

Arterial hypertension and coronary heart disease in real-world cardiology practice
by: S. A. Shalnova, et al.
Published: (2006-04-01)

Key data elements and definitions of the Russian registry of patients with arterial hypertension, coronary artery disease and chronic heart failure
by: Oshchepkova E.V., et al.
Published: (2014-06-01)

Objectives and design of Russian Registry of Hypertension, Coronary Artery Disease, and Chronic Heart Failure
by: Vladimir I. Gridnev, et al.
Published: (2017-05-01)

Arterial hypertension and coronary heart disease treatment compliance – a key factor in cardiovascular mortality reduction
by: G. V. Pogosova, et al.
Published: (2007-02-01)

PRE-HOSPITAL TREATMENT EFFECTIVENESS IN ATRIAL FIBRILLATION PAROXYSMS AMONG PATIENTS WITH ARTERIAL HYPERTENSION AND CORONARY HEART DISEASE
by: V. G. Epifanov, et al.
Published: (2010-06-01)

Cannot write session to /tmp/vufind_sessions/sess_eo7v93g4d211v6s9j68g5drani